Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00287781 · ClinicalTrials.gov registry record · NA
A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
A NA study, sponsored by Kern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00287781 is a NA study that has completed, run by Kern Medical Center. The registered enrollment target is 150 participants.
The verdict
NCT00287781, a NA study, has completed, sponsored by Kern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.
Interventions
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2002-01 |
| Est. Completion | 2006-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00287781
The ClinicalTrials.gov registry entry for NCT00287781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kern Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine is the first listed.
NCT00287781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00287781 about?
NCT00287781 is a clinical study titled "A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache". Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potentia...
What is the current status of trial NCT00287781?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2002-01. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00287781?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT00287781?
This trial is sponsored by Kern Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.